united states puerto ricans mexicans highest lowest asthma prevalence morbidity mortality respectively determine differences therapeutic response clinical response genetic factors contribute differences asthma outcomes compared clinical characteristics NUMBER mexican puerto rican individuals asthma recruited san francisco new york city puerto rico mexico city puerto ricans asthma reduced lung function greater morbidity longer asthma duration did mexicans asthma bronchodilator responsiveness measured percentage change baseline fev1 significantly lower puerto ricans asthma mexicans asthma puerto ricans asthma average NUMBER NUMBER confidence interval ci NUMBER NUMBER p NUMBER lower bronchodilator reversibility fev1 higher risk emergency department visit previous year odds ratio NUMBER NUMBER ci NUMBER NUMBER p NUMBER previous hospitalization asthma odds ratio NUMBER NUMBER ci NUMBER NUMBER p NUMBER mexicans subgroup analysis corroborated puerto ricans asthma severe disease did mexicans basis lung function measurements responsiveness agonists health care use conclude puerto ricans asthma respond albuterol mexicans asthma findings underscore need additional research differences asthma morbidity response therapy ethnicity specific asthma related beta2 adrenergic racial ethnic